The modified Glasgow Prognostic Score (mGPS) (Table 1) is a combination of C-reactive protein (CRP) and albumin, reflecting the inflammation and nutritional status of patients, and has an independent prognostic value for patients with various cancers, such as liver, lung, and colon cancer [14,15,16]. The gene discussed is CRP; the disease is cancer.